You have 9 free searches left this month | for more free features.

Notch Alterations

Showing 1 - 25 of 2,408

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

Recruiting
  • Breast Cancer
  • +7 more
  • Santa Monica, California
  • +19 more
Jan 6, 2022

Corneal Disease, Neuropathy, Dry Eye Disease Trial (Quantitative Sensory Test)

Not yet recruiting
  • Corneal Disease
  • +3 more
  • Quantitative Sensory Test
  • (no location specified)
Feb 24, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Shoulder Pain, Shoulder Impingement Syndrome Trial (ultrasound)

Not yet recruiting
  • Shoulder Pain
  • Shoulder Impingement Syndrome
  • ultrasound
  • (no location specified)
Aug 17, 2023

Lateral Femoral Impaction Fracture / Lateral Femoral Notch Sign

Recruiting
  • Anterior Cruciate Ligament Injuries
  • +2 more
  • Measurements on knee MRI performed during routine clinical practice
  • Bełchatów, Łódzkie, Poland
    Artromedical Orthopaedic Clinic
Jan 4, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma Trial in Houston (AL101, Therapeutic Conventional Surgery)

Recruiting
  • Adenoid Cystic Carcinoma
  • Metastatic Adenoid Cystic Carcinoma
  • AL101
  • Therapeutic Conventional Surgery
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Triple Negative Breast Cancer Trial in Worldwide (AL101)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Gilbert, Arizona
  • +28 more
Mar 31, 2022

Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

Recruiting
  • Severe Combined Immunodeficiency Disease, X-linked
  • CL20-i4-EF1α-hγc-OPT
  • +2 more
  • San Francisco, California
  • +2 more
Jan 9, 2023

Triple Negative Breast Tumors Trial in Worldwide (PF-03084014)

Terminated
  • Triple Negative Breast Neoplasms
  • Stanford, California
  • +36 more
Dec 19, 2018

Cannabis, Ketamine Trial in West Haven (Active Delta-9-THC, Placebo Delta-9-THC, Active Ketamine)

Recruiting
  • Cannabis
  • Ketamine
  • Active Delta-9-THC
  • +3 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Jan 27, 2022

Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)

Active, not recruiting
  • Desmoid Tumors
  • Aggressive Fibromatosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022

Exercise to Slow Cardiovascular Ageing Progression

Not yet recruiting
  • Cardiac Ageing
  • +2 more
    • Singapore, Singapore
      National Heart Centre Singapore
    Mar 7, 2023

    Vascular Diseases Trial in Mar del Plata (Finger photoplethysmography)

    Recruiting
    • Vascular Diseases
    • Finger photoplethysmography
    • Mar del Plata, Buenos Aires, Argentina
    • +1 more
    Jan 3, 2022

    Structural White and Gray Matter Correlates of Impaired Muscle

    Completed
    • Low Back Pain
    • +4 more
      • Ghent, Oost-Vlaanderen, Belgium
        Ghent University, vakgroep revalidatiewetenschappen
      Nov 15, 2023

      Tendinopathy Trial in Lyon (Endoscopic tenotomy surgery of the iliopsoas tendon)

      Not yet recruiting
      • Tendinopathy
      • Endoscopic tenotomy surgery of the iliopsoas tendon
      • Lyon, France
        Clinique de la Sauvegarde
      Jul 17, 2023

      Adenoid Cystic Carcinoma Trial in Worldwide (AL101)

      Active, not recruiting
      • Adenoid Cystic Carcinoma
      • Los Angeles, California
      • +16 more
      Dec 10, 2021

      Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Guanzhou, China
        SunYat-senU
      May 5, 2023

      Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

      Recruiting
      • Hepatitis B, Chronic
      • PEGylated recombinant human interferon alpha-2b injection
      • Hefei, Anhui, China
        The First Affiliated Hospital of Anhui Medical University
      Jun 24, 2023

      Epiction of Genomic and Genetic Landscape Identifies CCL5

      Completed
      • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
        • (no location specified)
        Jan 27, 2023

        Airway Management Trial in Brno (Laryngeal mask insertion)

        Recruiting
        • Airway Management
        • Laryngeal mask insertion
        • Brno, South Moravian Region, Czechia
          Brno University Hospital
        Jan 31, 2022

        Brain Metastases Trial (biological samples (blood test and lumbar puncture))

        Not yet recruiting
        • Brain Metastases
        • biological samples (blood test and lumbar puncture)
        • (no location specified)
        May 4, 2023

        Molecular Analysis and Treatment Options of Thymic Malignancies

        Recruiting
        • Thymic Epithelial Tumor
        • +2 more
        • Shanghai, Shanghai, China
          Xiaomin Niu
        Dec 28, 2022

        Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

        Recruiting
        • Advanced Solid Tumor
        • Tucson, Arizona
        • +199 more
        Jan 27, 2023

        Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney Trial in

        Not yet recruiting
        • Atypical Hemolytic Uremic Syndrome
        • +3 more
        • Skin biopsy
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
        Aug 9, 2023

        Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

        Recruiting
        • Solid Tumor
        • +4 more
        • Tianjin, Tianjin, China
          Tianjin Medical University Second Hospital
        Aug 28, 2023